{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urethritis-male/management/management/","result":{"pageContext":{"chapter":{"id":"b6607a10-84f2-51a2-ac03-a68ccb8dcbe9","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field c47ab973-c6da-4c04-a590-5a7c268050d4 --><h2>Scenario: Management of male urethritis</h2><!-- end field c47ab973-c6da-4c04-a590-5a7c268050d4 -->","summary":"Covers the management of male urethritis.","htmlStringContent":"<!-- begin item f3db08ad-fe37-470b-b51f-87ae100ee754 --><!-- begin field abb333ac-9735-46ef-8efd-acbc01564c6b --><p>From age 13 years onwards (Male).</p><!-- end field abb333ac-9735-46ef-8efd-acbc01564c6b --><!-- end item f3db08ad-fe37-470b-b51f-87ae100ee754 -->","topic":{"id":"f36465a1-1338-5604-8bb2-c8e555c598ae","topicId":"9d634e3c-7474-4d96-bbcb-7c29c10c1b03","topicName":"Urethritis - male","slug":"urethritis-male","lastRevised":"Last revised in September 2019","chapters":[{"id":"ac50911c-3aae-5117-95ce-67557d49723a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"ae05a825-47bf-5fc0-9065-c859d8427b3b","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1c94ea5f-b73f-51a3-9d99-83814d055e3f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8e3d5f57-add8-5b6f-bd13-9ea05bc5ec30","slug":"changes","fullItemName":"Changes"},{"id":"7353c5be-d0ed-506f-8487-265ce270e97f","slug":"update","fullItemName":"Update"}]},{"id":"644de86f-bfeb-5ebf-8cda-c1be15f8938a","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bd23c29c-af09-54b6-be4e-9f6ed812d62a","slug":"goals","fullItemName":"Goals"},{"id":"63346f4c-c71f-5887-b6d3-0d07661b1393","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"49121260-b8cb-5ecc-855a-f87303bc727e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"40b6a387-e841-594d-8616-fb4e8f4391e1","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7d3a51c9-f614-5196-8052-55ceb4b6cf08","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b2b68ef0-16c8-5dbc-b8f8-fbdfa673ed3f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"027c2bf3-1625-560c-902b-9fef54935849","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"95898c97-d200-5648-b696-7388ab850318","slug":"definition","fullItemName":"Definition"},{"id":"9b0e6aa9-b665-52de-bfa3-93f09f83bc3d","slug":"causes","fullItemName":"Causes"},{"id":"f9c36294-6c74-5b9e-8afb-65b38bfa14e1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2d0fc428-15ca-543a-bd93-b4ac231ed0cb","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"b7be062a-0eff-5e83-9493-809927e4776a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"60b1f452-fec4-567e-b8f0-39660841e61b","slug":"when-to-suspect-urethritis","fullItemName":"When to suspect urethritis"},{"id":"d5d984a2-a3d7-533a-9b94-02ac51c4fa07","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75471ada-cb93-59f3-97b0-3c182e9f80b7","fullItemName":"Management","slug":"management","subChapters":[{"id":"b6607a10-84f2-51a2-ac03-a68ccb8dcbe9","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"513fcd9d-25a9-5183-98b5-32bdef8e6d5a","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"6598b6d1-3e66-518c-9a8b-63eff17fecaf","slug":"doxycycline","fullItemName":"Doxycycline"},{"id":"c498c9de-1083-50a6-b290-ac30aebda851","slug":"azithromycin","fullItemName":"Azithromycin"},{"id":"ecf258dc-1499-5f7a-a781-6566ea1a4f54","slug":"ofloxacin","fullItemName":"Ofloxacin"},{"id":"f4c18a1e-b367-5433-ac91-efd9bce81a5e","slug":"metronidazole","fullItemName":"Metronidazole"}]},{"id":"221c9f46-f915-5e6f-8275-959420090646","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"25917416-1fc8-5919-9773-f3b7e054b6a0","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2ad44d6a-7cb1-598d-9dd4-9552f4f7fb49","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"791a5ccc-3882-5e9e-a55e-fc18bff5d67a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7370a44f-6a25-58d8-a772-568023fd6516","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"991288b5-d1b7-50f9-8e87-ceaf3331e0e2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"bf8f6743-57dd-5f6e-9460-bbecad8fd0b5","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"b2d086b7-cf3d-5d24-994a-e0280f2397db","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"75471ada-cb93-59f3-97b0-3c182e9f80b7","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"8ff907f5-262f-5097-bb76-ad36c7f165b8","slug":"management","fullItemName":"Management","depth":3,"htmlHeader":"<!-- begin field 7e11109b-7df3-4116-acb5-29453af99125 --><h3>How should I manage a man with suspected urethritis?</h3><!-- end field 7e11109b-7df3-4116-acb5-29453af99125 -->","summary":null,"htmlStringContent":"<!-- begin item bab9f573-73e9-464b-9cbb-f292162c315a --><!-- begin field 617b3e8d-1a03-414b-85c1-c5c74299f55e --><p><strong>Offer referral to <em>all </em>men with suspected urethritis to a genito-urinary medicine (GUM) clinic or other local specialist sexual health service for treatment. if referral is declined or not possible:</strong></p><ul><li><strong>Offer empirical treatment for chlamydial infection with </strong><strong>doxycycline 100 mg twice a day for 7 days. Where doxycycline is contraindicated or not tolerated, possible alternatives are:</strong><ul><li>Azithromycin 1 gram, single dose for 1 day then 500mg daily for 2 days (Note: people taking azithromycin should be advised to abstain from sexual intercourse until <em>14 days</em> after the start of treatment, and until symptoms have resolved).<em> </em></li><li>Ofloxacin 200mg twice daily or 400mg daily for 7 days.</li></ul></li><li><strong>If gonococcal urethritis is suspected </strong>(for example if there is a local outbreak of gonorrhoea), consider treating for gonorrhoea. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>.</li><li><strong>If trichomoniasis is suspected </strong>(for example if the man's partner has trichomoniasis), treat for trichomoniasis. For more information see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a>.</li><li><strong>As well as <a class=\"topic-reference internal-reference\" href=\"/topics/urethritis-male/diagnosis/when-to-suspect-urethritis/\">screening</a> for possible underlying causes of urethritis, screen for other STIs including syphilis and Human immunodeficiency virus (HIV) — </strong>for more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/syphilis/\">Syphilis</a> and <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>.</li><li><strong>Consider screening for hepatitis if the person is at high risk. </strong>For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-a/\">Hepatitis A</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>.</li><li><strong>If a urinary tract infection is suspected (for example if the man has urinary symptoms and a urine dipstick is positive for nitrite and leukocyte esterase), </strong>send a mid-stream urine sample for culture and sensitivity and treat as appropriate — for further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urinary-tract-infection-lower-men/\">Urinary tract infection (lower) - men</a>.</li><li><strong>Give advice about:</strong><ul><li>The most likely cause of urethritis which is usually, but not always, due to an STI.</li><li>The importance of adhering to treatment, as well as possible side effects.</li><li>Abstaining from sex (including oral sex) until he has completed treatment and treatment has also been completed by his partner(s).</li><li>The importance of safer sexual practices in reducing the future risk of acquiring STIs (for example the consistent and correct use of condoms, minimizing the number of sexual partners).<ul><li>Note: patient information leaflets on male urethritis are available from the <a data-hyperlink-id=\"01617773-58a4-4bd1-b031-aac9015c7465\" href=\"https://www.bashhguidelines.org/media/1040/ngu_pil_digital_2015.pdf\">British Association for Sexual Health and HIV (BASHH)</a> and the <a data-hyperlink-id=\"7f955cc3-1c20-49c6-ba03-aac9015c747b\" href=\"http://www.fpa.org.uk/sites/default/files/non-gonococcal-urethritis-information-and-advice.pdf\">Family Planning Association</a>.</li></ul></li></ul></li><li><strong>Advise the person that all their recent sexual partner(s) should be notified and advised to attend a genito-urinary medicine (GUM) clinic. </strong></li><li><strong>Arrange follow-up 1-2 weeks after treatment:</strong><ul><li>Review the person for persistent symptoms which may indicate <a class=\"topic-reference internal-reference\" href=\"/topics/urethritis-male/management/management/#treatment-failure\">treatment failure</a>.</li><li>Confirm that contact tracing has been carried out. The duration of contact tracing varies:<ul><li>For men who have tested positive for chlamydia, see the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>.</li><li>For men who have tested positive for gonorrhoea, see the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>.</li><li>For all other men, the recommended duration is all partners within the previous 4 weeks.</li></ul></li><li>Discuss the results of the STI screen and manage appropriately. For more information on detailed management see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/gonorrhoea/\">Gonorrhoea</a>, <a class=\"topic-reference external-reference\" href=\"/topics/chlamydia-uncomplicated-genital/\">Chlamydia - uncomplicated genital</a>, <a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>, <a class=\"topic-reference external-reference\" href=\"/topics/syphilis/\">Syphilis</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-a/\">Hepatitis A</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>.</li></ul></li></ul><!-- end field 617b3e8d-1a03-414b-85c1-c5c74299f55e --><!-- end item bab9f573-73e9-464b-9cbb-f292162c315a -->","subChapters":[{"id":"9ecbe1d9-e8ce-5dcd-aaa6-18809e49de4f","slug":"basis-for-recommendation-401","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 52c59aad-a182-4359-abf4-edc4fa4d5881 --><h4>Basis for recommendation</h4><!-- end field 52c59aad-a182-4359-abf4-edc4fa4d5881 -->","summary":null,"htmlStringContent":"<!-- begin item 4016f339-fd32-47bb-8f7b-9fc261940843 --><!-- begin field 7fd7f0cd-9bc8-47ac-9b17-032d92d2d8d0 --><p>The recommendations on management of urethritis are largely based on expert opinion in the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of non-gonococcal urethritis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2015a</a>], an update to this guideline which recommends use of doxycycline first-line [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2018</a>], and the Royal College of General Practitioners (RCGP) and BASHH guideline <em>Sexually Transmitted Infections in Primary Care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">RCGP, 2013</a>].</p><h5>Offering empirical antibiotic treatment</h5><ul><li>The recommendation to treat empirically for <em>Chlamydia </em><em>trachomatis </em>is based on expert opinion from Scottish guidelines <em>Urethral Discharge (Males) </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">NHS Lothian, 2008</a>]. It is not possible to accurately clinically distinguish between gonococcal urethritis and non-gonococcal urethritis. However, chlamydia is the infection most commonly associated with urethritis. Empirical treatment alleviates symptoms, reduces ongoing transmission and halts the spread of infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">RCGP, 2013</a>].</li></ul><h5>Use of doxycycline first-line</h5><ul><li>Doxycycline is recommended as first-line treatment for non-gonococcal urethritis to avoid macrolide resistance in <em>Mycoplasma genitalium (Mgen). </em>BASHH states that <em>'</em>The prevalence of pre-treatment macrolide resistance in <em>Mgen</em> in the United Kingdom is almost certainly >40%, which is probably due to the widespread use of azithromycin 1g to treat STIs and the limited availability of diagnostic tests for <em>Mgen. </em>Treatment with doxycycline reduces the Mgen load and risk of azithromycin selecting and/or inducing macrolide resistance' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2018</a>].</li></ul><h5>Trichomoniasis</h5><ul><li>The recommendation to consider treating for trichomoniasis if this is has been confirmed in the man's sexual partner is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><h5>Screening for hepatitis</h5><ul><li>The recommendation to consider screening for hepatitis screening is based on expert opinion in the BASHH guideline <em>Summary guidance on tests for sexually transmitted infections </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2015b</a>].</li></ul><!-- end field 7fd7f0cd-9bc8-47ac-9b17-032d92d2d8d0 --><!-- end item 4016f339-fd32-47bb-8f7b-9fc261940843 -->","subChapters":[]}]},{"id":"c2f72dc2-0886-503b-bdae-395ad95c860d","slug":"treatment-failure","fullItemName":"Treatment failure","depth":3,"htmlHeader":"<!-- begin field 2689ebc5-307c-4bb5-813a-7d9db4c9ff1c --><h3>How should I manage treatment failure?</h3><!-- end field 2689ebc5-307c-4bb5-813a-7d9db4c9ff1c -->","summary":null,"htmlStringContent":"<!-- begin item f1a0a3a2-da2a-46d0-b64b-239fef2855f7 --><!-- begin field 4ad02089-29f2-4716-b625-635c1e15decc --><ul><li><strong>If symptoms persist or recur after treatment is completed, <em>strongly </em>advise the person to attend a genito-urinary medicine (GUM) clinic or other local specialist sexual health service. </strong>If this is declined or not possible:<ul><li>Check adherence to the drug treatment regime.</li><li>Exclude the possibility of re-infection. Check that current partner(s) have been treated appropriately and simultaneously.</li><li>Reconsider the diagnosis. Ensure that other <a class=\"topic-reference internal-reference\" href=\"/topics/urethritis-male/background-information/causes/\">causes</a> of symptoms or <a class=\"topic-reference internal-reference\" href=\"/topics/urethritis-male/diagnosis/differential-diagnosis/\">alternative diagnoses</a> have been excluded.</li><li>If treated with doxycycline regimen first line, then prescribe Azithromycin 1g stat then 500 mg once daily for the next 2 days, plus metronidazole 400mg twice daily for five days.</li><li>Azithromycin should be started within 2 weeks of finishing doxycycline.</li><li>Patients should be advised to abstain from sexual intercourse until 14 days after the start of treatment and until symptoms have resolved.</li><li>If treated with azithromycin regimen first line, then prescribe Moxifloxacin 400mg once daily for 10 days, plus metronidazole 400mg twice daily for five days.<ul><li>Or alternatively, prescribed Doxycycline 100mg twice daily for 7 days, plus metronidazole 400mg twice daily for five days. (Note: if <a class=\"topic-reference internal-reference\" href=\"/topics/urethritis-male/diagnosis/when-to-suspect-urethritis/\">Mycoplasma genitalium detection assays</a> have not been carried out and a negative result has not been confirmed, consider trying this regimen rather then using moxifloxacin).</li></ul></li><li>If symptoms persist despite a second course of antibiotics, seek specialist advice.</li></ul></li></ul><!-- end field 4ad02089-29f2-4716-b625-635c1e15decc --><!-- end item f1a0a3a2-da2a-46d0-b64b-239fef2855f7 -->","subChapters":[{"id":"8b05c07e-b763-5ac8-ae5b-7a0f6c4ab052","slug":"basis-for-recommendation-40e","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 163aa622-4264-4563-8ea7-f941a0dad761 --><h4>Basis for recommendation</h4><!-- end field 163aa622-4264-4563-8ea7-f941a0dad761 -->","summary":null,"htmlStringContent":"<!-- begin item 40e50766-adb6-4626-b950-aad927323f6f --><!-- begin field fcda512a-1d87-47f7-8568-33e55a4df178 --><p>The recommendations on managing treatment failure for urethritis are largely based on expert opinion in the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of non-gonococcal urethritis </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2015a</a>], a partial update to this guideline which alters some treatment recommendations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2018</a>], and the Royal College of General Practitioners (RCGP) and BASHH guideline <em>Sexually Transmitted Infections in Primary Care</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">RCGP, 2013</a>].</p><h5>Referral to genito-urinary medicine (GUM) clinic or other local specialist sexual health service</h5><ul><li>The recommendation to strongly advise referral for all men with persistent or recurrent urethritis is pragmatic, based on what CKS considers to be good clinical practice. Establishing an accurate diagnosis of ongoing urethritis is central to management and can usually only be undertaken by a trained specialist.</li><li>The cause of persistent or recurrent urethritis following treatment is complex and poorly understood and thought to be multifactorial. An infective cause has been identified in less than 50% of cases. <em>Mycoplasma genitalium </em>infection has been identified in 20–40% of men with persistent or recurrent urethritis and <em>Ureaplasma urealyticum </em>has also been implicated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urethritis-male/references/\">BASHH, 2015a</a>].</li></ul><h5>Seeking specialist advice</h5><ul><li>The recommendation to seek specialist advice if symptoms persist after a second course of antibiotics is pragmatic based on what CKS considers to be good clinical practice.</li></ul><!-- end field fcda512a-1d87-47f7-8568-33e55a4df178 --><!-- end item 40e50766-adb6-4626-b950-aad927323f6f -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}